Article in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Hannah M VoorheesDepartment of Pharmacology (H.M.V., J.L.T., J.W.H., M.N.-C., M.M-A.B., M.F.N.), University of California, Davis.ORCID 0009-0007-1289-8267
Jade L TaylorDepartment of Pharmacology (H.M.V., J.L.T., J.W.H., M.N.-C., M.M-A.B., M.F.N.), University of California, Davis.ORCID 0000-0001-7158-2712
Maartje WesthoffDepartment of Physiology and Membrane Biology (M.W., R.E.D.), University of California, Davis.ORCID 0000-0002-5421-8609
Johannes W HellDepartment of Pharmacology (H.M.V., J.L.T., J.W.H., M.N.-C., M.M-A.B., M.F.N.), University of California, Davis.ORCID 0000-0001-7960-7531
Rose E DixonDepartment of Physiology and Membrane Biology (M.W., R.E.D.), University of California, Davis.ORCID 0000-0003-0655-690X
Madeline Nieves-CintrónDepartment of Pharmacology (H.M.V., J.L.T., J.W.H., M.N.-C., M.M-A.B., M.F.N.), University of California, Davis.ORCID 0000-0003-1935-8400
Miguel Martín-Aragón BaudelDepartment of Pharmacology (H.M.V., J.L.T., J.W.H., M.N.-C., M.M-A.B., M.F.N.), University of California, Davis.ORCID 0000-0001-9399-4013
Manuel F NavedoDepartment of Pharmacology (H.M.V., J.L.T., J.W.H., M.N.-C., M.M-A.B., M.F.N.), University of California, Davis.ORCID 0000-0001-6864-6594
Funding
Coupling of Vascular Cav1.2 Channels In Health & DiseaseR01HL121059 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2015 to 2024
$4.5M
Molecular choreography of CaV1.2 channels in the aging myocardiumR01AG063796 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Rose Ellen Dixon · 2019 to 2026
$3.1M
cAMP signaling in vascular smooth muscle in health and diseaseR01HL161872 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2022 to 2025
$2.6M
Lipid regulation of Cardiac Excitation-Contraction couplingR01HL159304 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DIXON, ROSE ELLEN · 2022 to 2025
$2.4M
Training Program in PharmacologyT32GM144303 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, JOHANNES W HELL · 2022 to 2026
$2.1M
Mechanisms of VSM dysfunction in diabetes and HFpEFR01HL171014 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Manuel F Navedo, Madeline Nieves-Cintron · 2024 to 2026
$2.0M
Pressure Regulation of Vascular CaV1.2 ChannelsR01HL180444 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Manuel F Navedo · 2025 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Context-Dependent Control: PKA Regulation of Vascular Ca · full record | Socratic